Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema
Clinical trial NCT05355818 · COMPLETED
Trial details
- NCT number
- NCT05355818
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2024-12-05
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.